Showing results (91-100 of 1,142) with videos related to
Sort By:
Pageof 115
Hepatology Communications|June 7, 2019
Liver Macrophages: Old Dogmas and New InsightsAdrien Guillot, Frank TackeExpert Review of Gastroenterology & Hepatology|September 29, 2018
An update on the recent advances in antifibrotic therapyFrank Tacke, Ralf WeiskirchenClinical Science (London, England : 1979)|March 17, 2018
Liver inflammation and regeneration in drug-induced liver injury: sex matters!Salvatore Sutti, Frank TackeOncoimmunology|November 20, 2012
Distinct anti-tumoral functions of adaptive immune cells in liver cancerCarlo Schneider, Frank TackeCell Metabolism|January 7, 2026
Acetyl-CoA-producing enzymes are a targetable metabolic entry point to MASLD and liver fibrosisIsabella Lurje, Frank TackeWorld Journal of Gastrointestinal Pathophysiology|June 4, 2014
Role of gamma-delta T cells in liver inflammation and fibrosisLinda Hammerich, Frank TackeEgastroenterology|June 13, 2025
Key takeaways from the updated multidisciplinary European MASLD guidelinesPaul Horn, Frank TackeHepatology Communications|July 5, 2024
Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal contextAdrien Guillot, Frank TackeExpert Opinion on Pharmacotherapy|July 2, 2024
Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?Tobias Puengel, Frank TackeMetabolism: Clinical and Experimental|August 31, 2024
Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignanciesTian Lan, Frank TackePageof 115